首页> 外文期刊>Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology >The effect of different progestogens on sleep in postmenopausal women: a randomized trial
【24h】

The effect of different progestogens on sleep in postmenopausal women: a randomized trial

机译:不同孕激素对绝经后妇女睡眠的影响:随机试验

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: While progesterone affects sleep, different types of it might affect sleep differently.Methods: One hundred Thai women, who complained of insomnia, visited the Menopause Clinic at Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand from February 2014 to March 2015, and were divided randomly into two groups. Both groups received daily hormonal treatment that included estradiol valerate (progynova) at 1mg. The first group also received dydrogesterone (duphaston((R))) at 10mg and the second group micronized progesterone (utrogestran((R))) at 100mg. The clinical symptoms and Pittsburgh Sleep Quality Index (PSQI) were recorded for three consecutive months after treatment. This study was registered with clinicaltrial.gov (code number NCT02086032).Results: Sleep quality improved in both groups (10.524.27 to 4.913.15 in the dydrogesterone group and 10.163.60 to 6.273.04 in the micronized progesterone group, pvalue 0.08). Women in the micronized progesterone group had fewer overall side effects than those in the dydrogesterone group.Conclusion: Sleep quality of peri-postmenopausal women with insomnia improved dramatically after the first month of hormonal treatment. However, more participating patients are necessary to ascertain the differences in sleep quality from dydrogesterone and micronized progesterone treatment.
机译:背景:虽然黄体酮影响睡眠,但它的不同类型可能会影响睡眠。曾经抱怨的睡眠:抱怨失眠的泰国妇女在2014年2月至2015年2月举行了Maharaj Nakorn Chiang Mai医院的更年期诊所,并随机分为两组。两组接受每日激素治疗,其中包括雌二醇符号(Progynova)在1mg下。第一组还在10mg和第二组微粉化孕酮(乌斯科((r)))下接受莫司酮(Duphaston((r))),如100mg。治疗后连续三个月记录临床症状和匹兹堡睡眠质量指数(PSQI)。本研究在ClinicalTrial.gov(代码编号NCT02086032)中注册。结果:睡眠质量在两组(10.524.27至4.913.15至4.913.15〜4.913.15中,10.163.60〜6.273.04在微粉化黄体酮组中,Pvalue 0.08 )。微粉化孕酮组的妇女总体副作用比莫德英酮群体较少。结论:在荷尔蒙治疗的第一个月后,患有失眠症的脑绝经质妇女的睡眠质量急​​剧提高。然而,更多的参与患者是必要的,以确定来自Dydritgerone和微粉化孕酮治疗的睡眠质量的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号